My Profile
Felix Salmon
Unleashed on Reuters
Blogging the financial meltdown
See all posts
Wed 2 Dec 2009 | 0:16 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Novogen Ltd
Novogen Ltd (NVGN.O) (Consolidated Issue listed on NASDAQ Global Market)
sector:
Healthcare
.
industry:
Biotechnology
ยท
View
NVGN
on other exchanges
As of 1 Dec 2009
2.37
USD
Price Change
+0.00
Percent Change
+0.02%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Age
Since
Current Position
Lancaster, Warren
--
--
Vice President - Commercial and Corporate Development, US
Nestel, Paul
79
2001
Non-Executive Director
Leppinus, Geoffrey
--
2005
Non-Executive Director
Rueckert, William
55
2009
Non-Executive Director
Johnston, Philip
61
2001
Non-Executive Chairman of the Board
Palmer, Bryan
--
--
General Manager - Operations
Kearney, Craig
--
2001
General Manager - Consumer Business
Husband, Alan
--
2006
Executive Director
Erratt, Ronald
--
1994
Company Secretary
Seaton, David
54
--
Chief Financial Officer
Find out more about NVGN.O
Insider Trading